{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:11:53Z","timestamp":1790683913994,"version":"4.1.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,17]]},"DOI":"10.7759\/cureus.75882","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T16:15:06Z","timestamp":1734452106000},"source":"Crossref","is-referenced-by-count":1,"title":["A Rare Case of Erythromycin-Induced Rhabdomyolysis"],"prefix":"10.7759","author":[{"given":"Zaid","family":"Khamis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Aldalahmeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saif","family":"Abu-Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Khattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/cc13897","article-title":"Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review","volume":"18","author":"Petejova N","year":"2014","unstructured":"Petejova N, Martinek A. Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review. Crit Care. 2014, 18:224. 10.1186\/cc13897","journal-title":"Crit Care"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2020.101015","article-title":"Rhabdomyolysis","volume":"66","author":"Cabral BM","year":"2020","unstructured":"Cabral BM, Edding SN, Portocarrero JP, Lerma EV. Rhabdomyolysis. Dis Mon. 2020, 66:101015. 10.1016\/j.disamonth.2020.101015","journal-title":"Dis Mon"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2021.09.025","article-title":"Rhabdomyolysis: a syndrome to be considered","volume":"158","author":"Baeza-Trinidad R","year":"2022","unstructured":"Baeza-Trinidad R. Rhabdomyolysis: a syndrome to be considered. Med Clin (Barc). 2022, 158:277-83. 10.1016\/j.medcli.2021.09.025","journal-title":"Med Clin (Barc)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0801327","article-title":"Rhabdomyolysis and acute kidney injury","volume":"361","author":"Bosch X","year":"2009","unstructured":"Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med. 2009, 361:62-72. 10.1056\/NEJMra0801327","journal-title":"N Engl J Med"},{"key":"ref5","article-title":"Rhabdomyolysis: pathogenesis, diagnosis, and treatment","volume":"15","author":"Torres PA","year":"2015","unstructured":"Torres PA, Helmstetter JA, Kaye AM, Kaye AD. Rhabdomyolysis: pathogenesis, diagnosis, and treatment. Ochsner J. 2015, 15:58-69.","journal-title":"Ochsner J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2010.151","article-title":"Rhabdomyolysis: historical background, clinical, diagnostic and therapeutic features","volume":"48","author":"Cervellin G","year":"2010","unstructured":"Cervellin G, Comelli I, Lippi G. Rhabdomyolysis: historical background, clinical, diagnostic and therapeutic features. Clin Chem Lab Med. 2010, 48:749-56. 10.1515\/CCLM.2010.151","journal-title":"Clin Chem Lab Med"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.5492\/wjccm.v3.i1.","article-title":"Rhabdomyolysis, compartment syndrome and thermal injury","volume":"3","author":"Coban YK","year":"2014","unstructured":"Coban YK. Rhabdomyolysis, compartment syndrome and thermal injury. World J Crit Care Med. 2014, 3:1-7.","journal-title":"World J Crit Care Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S214938","article-title":"The clinical significance of statins-macrolides interaction: comprehensive review of in vivo studies, case reports, and population studies","volume":"15","author":"Abu Mellal A","year":"2019","unstructured":"Abu Mellal A, Hussain N, Said AS. The clinical significance of statins-macrolides interaction: comprehensive review of in vivo studies, case reports, and population studies. Ther Clin Risk Manag. 2019, 15:921-36. 10.2147\/TCRM.S214938","journal-title":"Ther Clin Risk Manag"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.38605","article-title":"Rhabdomyolysis associations with antibiotics: a pharmacovigilance study of the FDA Adverse Event Reporting System (FAERS)","volume":"16","author":"Teng C","year":"2019","unstructured":"Teng C, Baus C, Wilson JP, Frei CR. Rhabdomyolysis associations with antibiotics: a pharmacovigilance study of the FDA Adverse Event Reporting System (FAERS). Int J Med Sci. 2019, 16:1504-9. 10.7150\/ijms.38605","journal-title":"Int J Med Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S29845","article-title":"Clarithromycin-induced rhabdomyolysis: a case report","volume":"5","author":"Pasqualetti G","year":"2012","unstructured":"Pasqualetti G, Bini G, Tognini S, Polini A, Monzani F. Clarithromycin-induced rhabdomyolysis: a case report. Int J Gen Med. 2012, 5:283-5. 10.2147\/IJGM.S29845","journal-title":"Int J Gen Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e31819e221f","article-title":"Rhabdomyolysis following clarithromycin monotherapy","volume":"338","author":"Brener ZZ","year":"2009","unstructured":"Brener ZZ, Bilik I, Khorets B, Winchester JF, Bergman M. Rhabdomyolysis following clarithromycin monotherapy. Am J Med Sci. 2009, 338:78. 10.1097\/MAJ.0b013e31819e221f","journal-title":"Am J Med Sci"},{"key":"ref12","article-title":"Monotherapy with erythromycin results in severe rhabdomyolysis","volume":"7","author":"Birkner L","year":"2016","unstructured":"Birkner L, Zolotov D, and Iasevoli M. Monotherapy with erythromycin results in severe rhabdomyolysis. Case Rep. 2016, 7:551-3.","journal-title":"Case Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5863\/1551-6776-16.3.216","article-title":"Rhabdomyolysis following a short course of clarythromycin","volume":"16","author":"Schor AM","year":"2011","unstructured":"Schor AM, Hellerstein A. Rhabdomyolysis following a short course of clarythromycin. J Pediatr Pharmacol Ther. 2011, 16:216-7. 10.5863\/1551-6776-16.3.216","journal-title":"J Pediatr Pharmacol Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/325265-a-rare-case-of-erythromycin-induced-rhabdomyolysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T16:15:08Z","timestamp":1734452108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/325265-a-rare-case-of-erythromycin-induced-rhabdomyolysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,17]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.75882","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,17]]}}}